Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Price:
9.405
USD
-36.5%
Market Cap:
$4.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
KR |
|
D-Wave Quantum Inc
F:RQ0
|
US |
|
Bloomsbury Publishing PLC
F:5JZ
|
UK |
|
U
|
UDMTek Co Ltd
KOSDAQ:389680
|
KR |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
|
H
|
Hongkong Chinese Ltd
HKEX:655
|
HK |
|
Zug Estates Holding AG
F:ZEE
|
CH |
|
R
|
River Valley Community Bancorp
OTC:RVCB
|
US |
|
Oriental Consultants Holdings Co Ltd
TSE:2498
|
JP |
|
Asahi Net Inc
TSE:3834
|
JP |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
HK |
|
VAT Group AG
SIX:VACN
|
CH |
|
C
|
Cyfrowy Polsat SA
WSE:CPS
|
PL |
|
Coloplast A/S
CSE:COLO B
|
DK |
Wall St Price Targets
IOVA Price Forecast
Based on 12 analysts
Based on 12 analysts
+68% Upside
from
$9.405
today
Iovance Biotherapeutics Inc (IOVA)’s 12-month stock price forecast through October 2027 has a consensus target of $15.81, implying 68% upside. The forecast is based on price targets from 12 Wall Street analysts.
IOVA Analyst Rating
Based on 10 analysts
Based on 10 analysts
Analysts rate IOVA Buy, with 8 of 10 recommending Buy or Strong buy.
Iovance Biotherapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
15.81
USD
15.81
USD
According to Wall Street analysts, the average 1-year price target for IOVA is 15.81 USD with a low forecast of 7.07 USD and a high forecast of 21 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
34%
34%
The compound annual growth rate for Revenue over the next 8 years is 34%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
48%
48%
The compound annual growth rate for Gross Profit over the next 8 years is 48%.